1 |
Abramowicz JS, Timmerman D. Ovarian mass-differentiating benign from malignant: the value of the International Ovarian Tumor Analysis ultrasound rules [J]. Am J Obstet Gynecol, 2017, 217(6): 652-660.
|
2 |
Siegiel R, Miller K, Jemal A. Cancer statistics, 2017 [J]. CA Cancer J Clin, 2017, 67(1): 7-30.
|
3 |
American College of Obstetricians and Gynecologists. Committee Opinion No. 477: The role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer [J]. Obstet Gynecol, 2011, 117(3): 742-746.
|
4 |
Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer [J]. Br J Obstet Gynaecol, 1990, 97(10): 922-929.
|
5 |
Aktürk E, Karaca RE, Alanbay İ, et al. Comparison of four malignancy risk indices in the detection of malignant ovarian masses [J]. J Gynecol Oncol, 2011, 22(3): 177-182.
|
6 |
Lou HY, Meng H, Zhu QL, et al. Application values of four risk of malignancy indices in the preoperative evaluation of patients with adnexal masses [J]. Zhongguo yi xue ke xue Yuan xue bao, 2010, 32(3): 297-302.
|
7 |
梁爽,任芸芸,李笑天. CA125,超声检查及恶性风险指数(RMI)对绝经后妇女卵巢肿瘤的诊断价值 [J]. 复旦学报(医学版), 2012, 39(4): 376-379.
|
8 |
Tingulstad S, Hagen B, Skjeldestad FE, et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses [J]. Br J Obstet Gynaecol, 1996, 103(8): 826-831.
|
9 |
Tingulstad S, Hagen B, Skjeldestad FE, et al. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals [J]. Obstet Gynecol, 1999, 93(3): 448-452.
|
10 |
Yamamoto Y, Yamada R, Oguri H, et al. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses [J]. Eur J Obstet Gynecol Reprod Biol, 2009, 144(2): 163-167.
|
11 |
Morgante G, La Marca A, Ditto A, et al. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses [J]. Br J Obstet Gynaecol, 1999, 106(6): 524-527.
|
12 |
Torres JCC, Derchain SFM, Faúndes A, et al. Risk-of-malignancy index in preoperative evaluation of clinically restricted ovarian cancer [J]. Sao Paulo Med J, 2002, 120(3): 72-76.
|
13 |
Clarke SE, Grimshaw R, Rittenberg P, et al. Risk of malignancy index in the evaluation of patients with adnexal masses [J]. J Obstet Gynaecol Can, 2009, 31(5): 440-445.
|
14 |
刘召芬,刘韶平,康德英, 等. 以血清CA125,绝经状态和超声检查评分预测卵巢肿瘤患者术前恶性危险指数 [J]. 现代妇产科进展, 2001, 10(1): 17-19.
|
15 |
王黎明,傅庆诏,刘韶平, 等. 三种恶性风险指数在附件肿块良恶性判断中的价值 [J]. 中国肿瘤临床, 2004, 31(16): 921-924.
|
16 |
Khoiwal K, Bahadur A, Kumari R, et al. Assessment of diagnostic value of Serum Ca-125 and risk of malignancy index scoring in the evaluation of adnexal masses [J]. J Midlife Health, 2019, 10(4): 192-196.
|
17 |
Van Trappen PO, Rufford BD, Mills TD, et al. Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, magnetic resonance imaging, and radioimmunoscintigraphy [J]. Int J Gynecol Cancer, 2007, 17(1): 61-67.
|
18 |
Ulusoy S, Akbayir O, Numanoglu C, et al. The risk of malignancy index in discrimination of adnexal masses [J]. Int J Gynecol Obstet, 2007, 96(3): 186-191.
|